Search

everythinglearnresearchcommunity

for

Search:↓

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Asthma may increase the risk of alopecia areata.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

Children with atopic diseases have a higher risk of developing alopecia areata.

Dental care may help improve hair loss in alopecia patients.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

Mechanical stimulation and new therapies show promise for hair regrowth.

New hair regrowth therapies show promise but need more research.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with alopecia areata often have lower vitamin D levels than healthy people.